British pharmaceutical company GlaxoSmithKline (GSK) says its new drug Sotrovimab Corona is also proving effective against the new variant Omi croon.
GSK says it is working with US company VIR biotechnology on Sotrovimab, an effective drug against corona virus, and research so far has shown that Sotrovimab also works against Corona’s Omi Crohn’s variant.
gsk says that corona therapy pre-clinical analysis has shown positive results against sotrovimab omi cron variant and further tests will be done to get more solid results of antibody treatment against omi cron variant.
